Professor Scott Bell

Professor Scott Bell is the Chair of Research, Gold Coast Health and Griffith University, a Senior Physician at the Department of Respiratory Medicine, Gold Coast Health, as well as a Senior Physician of the Adult Cystic Fibrosis Centre at The Prince Charles Hospital in Brisbane where he has worked since 1996 and was Director from 1996 to 2015. As a clinician scientist, he also leads the Lung Bacteria Laboratory at The University of Queensland. Scott is the current Queensland Biomedical Advisor.

As CEO of the Translational Research Institute in Brisbane from 2020 to January 2025, he led the institute to develop translational outcomes and build strong links with MedTech companies, successfully received funding to build a GMP manufacturing facility ($80 million) and established a program for training in research translation. Prior to that, from 2016 to 2020 he was the inaugural Executive Director, Research at Metro North Health.

Scott has more than 300 peer-reviewed publications and has received grant support of more than $24 million over the past 10 years. His research interests include acquisition and transmission pathways for human infection and his multi-disciplinary research has resulted in significant changes to clinical practice and policy implementation globally.

He has been principal investigator on numerous pivotal CFTR modulator trials. He was the Editor of the Journal of Cystic Fibrosis from 2013 until 2020 and co-led the Lancet Commission on the future of CF care which was published in 2020.